https://plkpathway.com/partial....ly-and-gene-sequenci
Temporary medical reaction and medical remission had been seen in respectively 61% and 31% after a median of 2.4 (1.3 - 3. months. After a median follow-up of 8.2 (5.6-12.4) months, 61% of patients remained treated with ustekinumab, and 26% in steroid-free medical remission. Among the list of 39 patients with colonoscopy during follow-up, 14 realized endoscopic remission (no ulcers). At the end of follow-up, 27% of patients were hospitalized, and 19% underwent intestinal resecti
Like
Comment
Share
